
|Articles|August 1, 2003
Supplements and Featured Publications
- Examining the Dyslipidemia Constellation
- Volume 9
- Issue 1 Dyslipid
NCEP ATP III guidelines incorporate global risk assessment
Author(s)Antionio M. Gotto, DPhil
Advertisement
Articles in this issue
over 22 years ago
Case reports illustrate consequences of ATP III in practiceover 22 years ago
Inflammatory markers are useful risk assessment toolsover 22 years ago
IVUS is redefining atherosclerotic diseaseNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol
2
Efficacy and Equity With Oral PCSK9s: Ann Marie Navar, MD, PhD
3
Mitigate Treatment Burden in Heart Failure: Martha Gulati, MD
4
Integrating Sotatercept Into PAH Care: Vallerie McLaughlin, MD
5
















































